Genetics of Congenital Heart Defects: A Candidate Gene Approach

Trends in Cardiovascular Medicine

Volumn 20, Issue 4, 2010, Pages 124-128

  Lagendijk, Anne Karine ^a   Smith, Kelly A ^c   Bakkers, Jeroen ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM 19 PROTEIN; ALK2 PROTEIN; APC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; FOXP1 PROTEIN; HYALURONIC ACID; PROTEIN; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE;

CELL PROLIFERATION; CONGENITAL HEART MALFORMATION; EMBRYO DEVELOPMENT; ENDOCARDIAL CUSHION; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEART DEVELOPMENT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

CELL PROLIFERATION; ENDOCARDIAL CUSHIONS; ENDOCARDIUM; HEART DEFECTS, CONGENITAL; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; HYALURONIC ACID; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION;

EID: 79951539210     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2010.10.003     Document Type: Review

References (41)

1. Armstrong E.J., Bischoff J. Heart valve development: endothelial cell signaling and differentiation. Circ Res 2004, 95:459-470.
2. Botto L.D., Correa A., Erickson J.D. Racial and temporal variations in the prevalence of heart defects. Pediatrics 2001, 107:E32.
3. Bourguignon L.Y., Peyrollier K., Gilad E., Brightman A. Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to β-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells. J Biol Chem 2007, 282:1265-1280.
4. Bourguignon L.Y., Xia W., Wong G. Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates β-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells. J Biol Chem 2009, 284:2657-2671.
5. Camenisch T.D., Schroeder J.A., Bradley J., et al. Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat Med 2002, 8:850-855.
6. Camenisch T.D., Spicer A.P., Brehm-Gibson T., et al. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 2000, 106:349-360.
7. Chen B., Bronson R.T., Klaman L.D., et al. Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat Genet 2000, 24:296-299.
8. Combs M.D., Yutzey K.E. Heart valve development: regulatory networks in development and disease. Circ Res 2009, 105:408-421.
9. De Caestecker M. The transforming growth factor-β superfamily of receptors. Cytokine Growth Factor Rev 2004, 15:1-11.
10. Erickson S.L., O'Shea K.S., Ghaboosi N., et al. ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. Development 1997, 124:4999-5011.
11. Garg V., Kathiriya I.S., Barnes R., et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003, 424:443-447.
12. Gruber P.J., Epstein J.A. Development gone awry: congenital heart disease. Circ Res 2004, 94:273-283.
13. Hoffman J.I., Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002, 39:1890-1900.
14. Horiuchi K., Zhou H.M., Kelly K., et al. Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins β1 and β2. Dev Biol 2005, 283:459-471.
15. Hurlstone A.F., Haramis A.P., Wienholds E., et al. The Wnt/β-catenin pathway regulates cardiac valve formation. Nature 2003, 425:633-637.
16. Iwamoto R., Yamazaki S., Asakura M., et al. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci U S A 2003, 100:3221-3226.
17. Jackson L.F., Qiu T.H., Sunnarborg S.W., et al. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. Embo J 2003, 22:2704-2716.
18. Jenkins K.J., Correa A., Feinstein J.A., et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007, 115:2995-3014.
19. Kim R.Y., Robertson E.J., Solloway M.J. Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. Dev Biol 2001, 235:449-466.
20. Kirk E.P., Sunde M., Costa M.W., et al. Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am J Hum Genet 2007, 81:280-291.
21. Kurohara K., Komatsu K., Kurisaki T., et al. Essential roles of Meltrin β (ADAM19) in heart development. Dev Biol 2004, 267:14-28.
22. Liu W., Selever J., Wang D., et al. Bmp4 signaling is required for outflow-tract septation and branchial-arch artery remodeling. Proc Natl Acad Sci U S A 2004, 101:4489-4494.
23. Lloyd-Jones D., Adams R.J., Brown T.M., et al. Heart disease and stroke statistics-2010 update: a report from the AmericanHeart Association. Circulation 2009, 121:e46-e215.
24. Lo R.S., Wotton D., Massague J. Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF. Embo J 2001, 20:128-136.
25. Ma L., Lu M.F., Schwartz R.J., Martin J.F. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 2005, 132:5601-5611.
26. Metzker M.L. Sequencing technologies-the next generation. Nat Rev Genet 2009, 11:31-46.
27. Mjaatvedt C.H., Lepera R.C., Markwald R.R. Myocardial specificity for initiating endothelial-mesenchymal cell transition in embryonic chick heart correlates with a particulate distribution of fibronectin. Dev Biol 1987, 119:59-67.
28. Person A.D., Klewer S.E., Runyan R.B. Cell biology of cardiac cushion development. Int Rev Cytol 2005, 243:287-335.
29. Rivera-Feliciano J., Lee K.H., Kong S.W., et al. Development of heart valves requires Gata4 expression in endothelial-derived cells. Development 2006, 133:3607-3618.
30. Rivera-Feliciano J., Tabin C.J. Bmp2 instructs cardiac progenitors to form the heart-valve-inducing field. Dev Biol 2006, 295:580-588.
31. Runyan R.B., Markwald R.R. Invasion of mesenchyme into three-dimensional collagen gels: a regional and temporal analysis of interaction in embryonic heart tissue. Dev Biol 1983, 95:108-114.
32. Schott J.J., Benson D.W., Basson C.T., et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998, 281:108-111.
33. Schroeder J.A., Jackson L.F., Lee D.C., Camenisch T.D. Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. J Mol Med 2003, 81:392-403.
34. Shirai M., Imanaka-Yoshida K., Schneider M.D., et al. T-box 2, a mediator of Bmp-Smad signaling, induced hyaluronan synthase 2 and Tgfβ2 expression and endocardial cushion formation. Proc Natl Acad Sci U S A 2009, 106:18604-18609.
35. Smith K.A., Joziasse I.C., Chocron S., et al. Dominant-negative ALK2 allele associates with congenital heart defects. Circulation 2009, 119:3062-3069.
36. Song L., Fassler R., Mishina Y., et al. Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. Dev Biol 2007, 301:276-286.
37. Sunnarborg S.W., Hinkle C.L., Stevenson M., et al. Tumor necrosis factor-α converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J Biol Chem 2002, 277:12838-12845.
38. Walsh E.C., Stainier D.Y. UDP-glucose dehydrogenase required for cardiac valve formation in zebrafish. Science 2001, 293:1670-1673.
39. Wang J., Sridurongrit S., Dudas M., et al. Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart. Dev Biol 2005, 286:299-310.
40. Ward C. Clinical significance of the bicuspid aortic valve. Heart 2000, 83:81-85.
41. Zhou H.M., Weskamp G., Chesneau V., et al. Essential role for ADAM19 in cardiovascular morphogenesis. Mol Cell Biol 2004, 24:96-104.